诺瓦瓦克斯医药 NVAX 深 沪
等待开盘 06-25 09:30:00 美东时间
8.895
-0.105
-1.17%
华盛通- 最 高9.36
- 今 开9.15
- 成交量 336.26万股
- 最 低 8.855
- 昨 收 9.00
- 总市值 14.63亿
- 52周最高 11.97
- 市盈率 静 3.50
- 换手率 2.04%
- 52周最低 6.20
- 委 比 55.67%
- 总股本 1.64亿
- 历史最高 331.68
- 量 比 0.66
- 振 幅 5.61%
- 历史最低 3.5324
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Novavax faces renewed attack by Shah Capital after AGM
Shah Capital, the largest shareholder of Novavax (NVAX), criticized the company’s leadership on Wednesday, even after the COVID-19 vaccine developer managed to get shareholder backing for all resoluti...
06-24 20:43
投资者密集搜索诺瓦瓦克斯医药（NVAX）：以下是你需要了解的信息
诺瓦瓦克斯（Novavax，股票代码NVAX）近期进入Zacks网站最高搜索量股票榜单，相关基本面因素可作为判断其短期走势的核心依据。 过去一个月，诺瓦瓦克斯股...
06-23 22:06
Novavax set for a seventh straight decline
Shares of Novavax (NVAX) fell 2.84% to $8.38 in the afternoon trade on Tuesday, adding to a six-session slide. The stock has fallen around 18% between June 1 and June 8, compared to a 2.56% decline in...
06-10 01:05
诺瓦瓦克斯15分钟图表显示布林带收窄、KDJ指标死叉
诺瓦瓦克斯医药公司（Novavax）15分钟图表近期布林带收窄，2026年6月2日13:30出现KDJ死叉。 布林带收窄是价格波动性降低的迹象，可能是重大价格变...
06-03 01:46
诺瓦瓦克斯医药2026年Q1业绩超预期，盘前股价显著上涨
经济观察网 诺瓦瓦克斯医药2026年第一季度业绩表现超出市场预期，推动盘前股价上涨，同时也存在相关经营风险。 业绩经营情况： 2026年Q1业绩超预期，营收1...
06-03 01:00
FDA AdCom panel to review and vote on next COVID shots
An advisory panel of the U.S. Food and Drug Administration will meet this week to discuss and vote on the composition of the 2026–2027 formula for COVID shots to be used during the next immunization d...
05-26 23:49
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG subvariant for the 2026-27 immunization campaign, accordin
05-26 22:52
Transcript: Dyadic International Q1 2026 Earnings Conference Call
Dyadic International (NASDAQ:DYAI) reported first-quarter financial results on ...
05-14 05:54
SanDisk's 4,000% Moonshot Just Made Its Parent The Underdog
SanDisk's post-spin rally has turned a separation story into a market-cap upset, with SNDK stock outperforming former parent WDC.
05-12 03:46
Rocket Lab Stock Gains Bullish Backing: Analyst Sees A SpaceX Challenger
Needham raises the price target on Rocket Lab and sees the company as a potential challenger to SpaceX.
05-12 00:09
